Document is current
Any future updates will be listed below
-
Authors
Pluta, Kathryn
Hohl, Sarah D.
D’Angelo, Heather
Ostroff, Jamie S.
Shelley, Donna
Asvat, Yasmin
Chen, Li-Shiun
Cummings, K. Michael
Dahl, Neely
Day, Andrew T.
Fleisher, Linda
Goldstein, Adam O.
Hayes, Rashelle
Hitsman, Brian
Buckles, Deborah Hudson
King, Andrea C.
Lam, Cho Y.
Lenhoff, Katie
Levinson, Arnold H.
Minion, Mara
Presant, Cary
Prochaska, Judith J.
Shoenbill, Kimberly
Simmons, Vani
Taylor, Kathryn
Tindle, Hilary
Tong, Elisa
White, Justin S.
Wiseman, Kara P.
Warren, Graham W.
Baker, Timothy B.
Rolland, Betsy
Fiore, Michael C.
Salloum, Ramzi G. https://orcid.org/0000-0002-8139-2418
-
Funding
Funding for this research was provided by:
National Cancer Institute (17GZSK0031)
- License Information
-
More Information
Article History
Received: 8 December 2022
Accepted: 2 May 2023
First Online: 11 May 2023
Declarations
:
: Data reported in this manuscript were collected for the purpose of program evaluation and quality improvement. The need for informed consent of participants was waived because programs participating in the evaluation provided deidentified, aggregated data. The evaluation was categorized as program evaluation and deemed exempt by the Institutional Review Board of the University of Wisconsin-Madison.
: We consent to publication.
: Dr. Baker occupies the Glaxo Wellcome Chair in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. Dr. Prochaska has provided consultation to pharmaceutical and technology companies that make medications and other treatments for quitting smoking and also has served as an expert witness in lawsuits against tobacco companies. The other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
